Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 2 MADRS scores of the study group and the control group at different time points

From: Correlations between major depressive disorder, splenic morphology, and immune function

Group

Time

Baseline

24 h

1 week

4 weeks

Study Group (n = 40)

37.65 ± 5.65

24.40 ± 11.83

22.28 ± 11.0.3

18.50 ± 10.35

Control Group (n = 40)

35.53 ± 7.33

35.53 ± 7.33

30.20 ± 6.75

23.35 ± 6.63

  1. Note: MADRS Montgomery–Åsberg Depression Rating Scale; both the study group and the control group were included in the MDD group, with (S)-ketamine as the intervention factor
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us